AtaiBeckley (ATAI) Non-Current Assets (2020 - 2026)

AtaiBeckley (ATAI) recorded quarterly Non-Current Assets of $409000.0 in Q1 2026.

AtaiBeckley (ATAI) Non-Current Assets (2020 - 2026) Analysis & Trends

AtaiBeckley has disclosed Non-Current Assets across 6 years of filings, most recently posting $409000.0 for Q3 2025.

  • Non-Current Assets for Q3 2025 came in at $409000.0, down 99.51% year-over-year; the trailing twelve-month figure through Sep 2025 was $409000.0 (changed N/A YoY), and the FY2020 annual result was $1.1 million, changed N/A from the prior year.
  • Non-Current Assets was $409000.0 for Q1 2026 at AtaiBeckley.
  • In the past five years, Non-Current Assets ranged from a high of $151.6 million in Q1 2024 to a low of $409000.0 in Q1 2025.
  • The 5-year median for Non-Current Assets is $5.5 million (2022), against an average of $32.7 million.
  • Across the five-year window, Non-Current Assets surged 2664.79% in 2024 and tumbled 99.73% in 2025, its largest moves.
  • AtaiBeckley's Non-Current Assets stood at $1.9 million in 2021, then surged by 211.71% to $6.1 million in 2022, then slipped by 9.64% to $5.5 million in 2023, then soared by 1421.61% to $83.4 million in 2024, then slumped by 99.51% to $409000.0 in 2025.
  • The last three Non-Current Assets figures came in at $409000.0 (Q3 2025), $409000.0 (Q2 2025), and $409000.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 AtaiBeckley 1.45 Bn 1.45 Bn - 409,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 409,000.00
Sep 30, 2025 409,000.00
Jun 30, 2025 409,000.00
Mar 31, 2025 409,000.00
Sep 30, 2024 83.45 Mn
Jun 30, 2024 97.87 Mn
Mar 31, 2024 151.62 Mn
Mar 31, 2023 5.48 Mn
Sep 30, 2022 6.07 Mn
Jun 30, 2022 6.64 Mn
Mar 31, 2022 5.55 Mn
Sep 30, 2021 1.95 Mn
Dec 31, 2020 1.05 Mn